Pattern of factor VIII inhibitors in patients with hemophilia A in the north east of Iran

Hematology

Volumn 11, Issue 3, 2006, Pages 215-217

  Modaresi, A R ^a   Mansouri Torghabeh, H ^b   Pourfathollah, A A ^b   Mahmoodian Shooshtari, M ^c   Rezaie Yazdi, Z ^d  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^d Internal ward of Ghaem Hospital   (Iran)

Author keywords

Factor VIII inhibitor; Hemophilia A; Iran; Khorasan province

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 CRYOPRECIPITATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; FRESH FROZEN PLASMA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; HEALTH SURVEY; HEMOPHILIA A; HUMAN; INFANT; IRAN; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODY SPECIFICITY; BLOOD COAGULATION TESTS; CHILD; CHILD, PRESCHOOL; FACTOR VIII; FEMALE; HEMOPHILIA A; HUMANS; IRAN; ISOANTIBODIES; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; SAMPLING STUDIES;

EID: 33748505225     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330600667526     Document Type: Article

References (16)

1. Speat, TH. (1972) Progress in hemostasis and thrombosis. USA: Grune & Stration.
2. Sohoppmann, A and Waytes, AT. (1996) Factor VIII inhibitor and severity of hemophilia Thromb Hemost, 76(2), pp. 275-281.
3. Mollison, PL and Engelfreit, CP and Cotreras, M. (1998) Blood transfusion in clinical edicine 10th ed. USA: Blackwell Science.
4. Oldenberg, J and Brackmann, HH and Sch-waab, R. (2000) Risk factor inhibitor development in hemophilia Haematologica, 85(10), pp. 8.
5. Kasper, CK and Aledort, LM and Counts, RB and Biggs, R and Rizza, C. (1975) A more uniform measurement of factor VIII inhibitors Thromb Diath Haemorr, 34, pp. 870.
6. Klinge, J and Auerswald, G and Budde, U and Kl-ose, H and Kreuz, W and Gringeri, A and Miraglia, S and (2002) Detection of all factor VIII antibodies in hemophilia A patients by bethesda assay and a more sensitive immunoprecipitation assay Hemophilia, 8, pp. 29.
7. Lossing, ST and Kasper, CK and Feinstein, DI and Counts, RB. (1997) Detection of factor VIII Inhibitor with the partial prothrombin time Blood, 49(7), pp. 741.
8. Chanarin, I and Gawley, JC and Contreras, M and Knight, RC and Machin, SJ.(1989) Laboratory hematology, an account of laboratory techniques 1st ed. USA: Churchill livingston.
9. Ehernforth, S and Kreuz, W and Scharrer, I and li-nde, R and Funk, M and Gian, P and (1992) Incidence of development of factor VIII and factor IX inhibitors in hemophilics Lancet, pp. 339-596.
10. Rothachild, C and laurian, Y and Stary, EP and Borel, A and Chanbost, H and Carel, D and (1998) French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII: Incidence of inhibitor and evaluation of immune tolerance Thromb Haemost, 80, pp. 779.
11. Rasi, V and Ikkala, E. (1990) Haemophilia with factor VIII inhibitors in Finland; prevalence, incidence and outcome BJH, 79, pp. 36.
12. Jeame, M. (2000) Inhibitor in young boys with hemophilia Res Clin Hematol, 13(3), pp. 457.
13. Bernard, Henry and Davidson, J.(1996) Clinical diagnosis and management by laboratory methods 9th ed. USA: WB Saunders.
14. Tadashi, K and Takahashi, I and Hidchiko, S and Saito, H. (1995) Retrospective study of inhibitor formation in Japanese hemophilia Inter J Hematol, 62, pp. 175.
15. Colvin, BT and Hay, CRM and Preston, FE and Hill, FGH. (1995) Incidence of factor VIII inhibitor in the United Kingdom BJH, 89, pp. 909.
16. Rosendeal, FR and Nieu wenhuis, HR and Vandenberg, H and Heijboer, H and Mauster, EP and Edvil, M and (1993) A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patient in The Netherland Blood, 81(8), pp. 2180.